Dosing patterns and clinical parameters in patients treated with sacubitril/valsartan in patients with heart failure

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 29 Nov 2018

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

14 Nov 2018 Results (n=1263) assessing changes in heart failure symptoms and referrals to hospital, presented at the 21st Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research
01 Apr 2018 Results comparing dosing patterns and changes in clinical parameters after Sacubitril/valsartan in patients from this trial and PARADIGM-HF, published in the Postgraduate Medicine
28 Nov 2017 New trial record

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com